Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Pharmazie ; 61(1): 4-9, 2006 Jan.
Article in German | MEDLINE | ID: mdl-16454197

ABSTRACT

The pyridone 1a reacts with POCl3/DMF to yield the title compound 2a. After irradiation of 2a the enolether 3 is isolated, as shown by an X-ray structure determination. The pyridine 4 obtained by dehydrogenation of 2a leads under reductive conditions to the benzo[c][2,7]naphthyridines 5-7. The reaction of 4 with o-phenylenediamine gives the benzimidazole 8, while using 2-aminophenol or 2-aminothiophene respectively the pyrido[2,3-b[1,5]benzoxazepine 11 and the corresponding benzothiazepine 12 are obtained.


Subject(s)
Heterocyclic Compounds/chemical synthesis , Nitro Compounds/chemical synthesis , Pyridines/chemical synthesis , Indicators and Reagents , Models, Molecular , X-Ray Diffraction
2.
Pharmazie ; 61(12): 975-80, 2006 Dec.
Article in German | MEDLINE | ID: mdl-17283651

ABSTRACT

The 2,5-dichlorobenzo[c][2,7]naphthyridine 6 was synthesized starting from the 2-pyridone 1 in four or five steps, respectively. The 5-yl amine 7 and the 2,5-diyl amines 8 and 9 were isolated by the reaction of compound 6 with the novaldiamine base. Starting with the reaction of the 6-chloropyridine 3 with the novaldiamine base to yield the 6-aminopyridine 11, the 2-yl amine 13, isomeric to 7, was obtained. Compounds 7-13 were tested for in vitro antimalarial activity using a chloroquine sensitive and resistant Plasmodium falciparum strain. The highest activity was shown by 8 with IC50 values of 90 nM and 190 nM, respectively.


Subject(s)
Antimalarials/chemical synthesis , Antimalarials/pharmacology , Naphthyridines/chemical synthesis , Naphthyridines/pharmacology , Animals , Chloroquine/pharmacology , Crystallography, X-Ray , Indicators and Reagents , Molecular Conformation , Plasmodium falciparum/drug effects , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL